Yusu Gu
About
Yusu Gu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience.
According to data from OpenAlex, Yusu Gu has authored 116 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Cardiology and Cardiovascular Medicine, 65 papers in Molecular Biology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yusu Gu's work include Cardiomyopathy and Myosin Studies (41 papers), Cardiovascular Effects of Exercise (26 papers) and Cardiac electrophysiology and arrhythmias (17 papers). Yusu Gu is often cited by papers focused on Cardiomyopathy and Myosin Studies (41 papers), Cardiovascular Effects of Exercise (26 papers) and Cardiac electrophysiology and arrhythmias (17 papers). Yusu Gu collaborates with scholars based in United States, China and Italy. Yusu Gu's co-authors include Kirk L. Peterson, Nancy D. Dalton, Ju Chen, Kenneth R. Chien, John Ross, John Ross, Masahiko Hoshijima, Sylvia Μ. Evans, Gianluigi Condorelli and You‐Yang Zhao and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.
In The Last Decade
Yusu Gu
110 papers receiving 8.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Yusu Gu United States | 45 | 5.2k | 4.3k | 1.1k | 930 | 920 | 116 | 8.7k | ||
| Nancy D. Dalton United States | 50 | 5.3k 1.0× | 4.2k 1.0× | 444 0.4× | 1.1k 1.2× | 1.0k 1.1× | 106 | 9.0k | ||
| Seiji Takashima Japan | 48 | 3.6k 0.7× | 2.1k 0.5× | 1.0k 1.0× | 1.2k 1.3× | 766 0.8× | 166 | 7.6k | ||
| Geir Christensen Norway | 44 | 3.2k 0.6× | 3.5k 0.8× | 571 0.5× | 555 0.6× | 909 1.0× | 213 | 6.8k | ||
| Mark A. Sussman United States | 61 | 7.3k 1.4× | 3.9k 0.9× | 846 0.8× | 1.5k 1.6× | 3.0k 3.3× | 193 | 11.9k | ||
| Hanna Osińska United States | 44 | 5.7k 1.1× | 3.2k 0.7× | 377 0.4× | 1.4k 1.5× | 473 0.5× | 89 | 8.2k | ||
| Michelle A. Sargent United States | 39 | 4.1k 0.8× | 2.3k 0.5× | 436 0.4× | 479 0.5× | 961 1.0× | 67 | 5.9k | ||
| Jutta Schaper Germany | 54 | 5.4k 1.0× | 5.6k 1.3× | 644 0.6× | 834 0.9× | 2.2k 2.4× | 214 | 11.8k | ||
| Michael Gotthardt Germany | 37 | 3.8k 0.7× | 2.2k 0.5× | 348 0.3× | 1.2k 1.3× | 646 0.7× | 87 | 6.8k | ||
| Christopher L. Antos Germany | 22 | 4.8k 0.9× | 2.1k 0.5× | 630 0.6× | 601 0.6× | 585 0.6× | 31 | 6.2k | ||
| Jane‐Lise Samuel France | 58 | 3.8k 0.7× | 3.7k 0.9× | 316 0.3× | 722 0.8× | 1.5k 1.7× | 184 | 8.0k |
Countries citing papers authored by Yusu Gu
Since
Specialization
Citations
This map shows the geographic impact of Yusu Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusu Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusu Gu more than expected).
Fields of papers citing papers by Yusu Gu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yusu Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusu Gu. The network helps show where Yusu Gu may publish in the future.
Co-authorship network of co-authors of Yusu Gu
This figure shows the co-authorship network connecting the top 25 collaborators of Yusu Gu. A scholar is included among the top collaborators of Yusu Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusu Gu. Yusu Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bogomolovas, Julius, Zengming Zhang, Yusu Gu, et al.. (2025). α Protein Kinase 3 Is Essential for Neonatal and Adult Cardiac Function. Journal of the American Heart Association. 14(7). e039464–e039464.
2.
Zhang, Zengming, Tongbin Wu, Zeyu Chen, et al.. (2025). Transcriptional readthrough at Atf4 locus suppresses Rps19bp1 and impairs heart development. Cardiovascular Research. 121(18). 2909–2921.
3.
Blondelle, Jordan, Matúš Soták, É. Estève, et al.. (2025). Combined Loss of Obsc and Obsl1 in Murine Hearts Results in Diastolic Dysfunction, Altered Metabolism, and Deregulated Mitophagy. Circulation Heart Failure. 18(4). e011867–e011867.
4.
Lee, Sharon, et al.. (2024). Dietary linoleic acid supplementation fails to rescue established cardiomyopathy in Barth syndrome. SHILAP Revista de lepidopterología. 8. 100076–100076.
5.
Wang, Zhe, Wei Chen, Yusu Gu, et al.. (2024). 755P A retrospective study on epidemiological and disease characteristics of Chinese NF1 patients in real-world: Promise study. Annals of Oncology. 35. S1683–S1684.
6.
Tan, Changming, Ze’e Chen, Canzhao Liu, et al.. (2021). Mediator complex proximal Tail subunit MED30 is critical for Mediator core stability and cardiomyocyte transcriptional network. PLoS Genetics. 17(9). e1009785–e1009785.
7.
Chen, Ze’e, Ying Shen, Leonardo J. Leon, et al.. (2021). Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy. Circulation Heart Failure. 14(6). e008289–e008289.
8.
Bogomolovas, Julius, Wei Feng, Lunfeng Zhang, et al.. (2020). Atypical ALPK2 kinase is not essential for cardiac development and function. American Journal of Physiology-Heart and Circulatory Physiology. 318(6). H1509–H1515.
9.
Liang, Yan, Robert C. Lyon, Jason Pellman, et al.. (2016). Abstract 20108: A Newly Identified Interaction Between Desmoplakin and COP9 Signalsome Subunit 6 Reveals a New Mechanism Underlying Sudden Death. Circulation. 134.
10.
Mir, Saiful A., Kuixing Zhang, Milos Milic, et al.. (2015). Analysis and validation of traits associated with a single nucleotide polymorphism Gly364Ser in catestatin using humanized chromogranin A mouse models. Journal of Hypertension. 34(1). 68–78.
11.
Moore‐Morris, Thomas, Nuno Guimarães‐Camboa, Indroneal Banerjee, et al.. (2014). Resident fibroblast lineages mediate pressure overload–induced cardiac fibrosis. Journal of Clinical Investigation. 124(7). 2921–2934.
12.
Ling, Haiyun, Tong Zhang, Laëtitia Pereira, et al.. (2012). Requirement for Ca 2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice (Journal of Clinical Investigation (2009) 119, 5, (1230-1240) doi: 10.1172/JCI38022). Journal of Clinical Investigation. 122(4).
13.
Sheikh, Farah, Kunfu Ouyang, Stuart G. Campbell, et al.. (2010). Abstract 17554: A Unique Synergistic Approach That Uncovers MLC2v Phosphorylation as an Early Marker for Heart Disease. Circulation. 122.
14.
Wright, Adam, Joyce Chuang, Kunfu Ouyang, et al.. (2008). Abstract 1429: Defects in Connexin Signaling Underlie Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in a Novel Mouse Model. Circulation. 118.
15.
Negro, Alejandra, Bhawanjit K. Brar, Yusu Gu, et al.. (2006). erbB2 is required for G protein-coupled receptor signaling in the heart. Proceedings of the National Academy of Sciences. 103(43). 15889–15893.
16.
Trifilo, Matthew J., Toshitaka Yajima, Yusu Gu, et al.. (2006). Prion-Induced Amyloid Heart Disease with High Blood Infectivity in Transgenic Mice. Science. 313(5783). 94–97.
17.
Iwanaga, Yoshitaka, Masahiko Hoshijima, Yusu Gu, et al.. (2004). Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. Journal of Clinical Investigation. 113(5). 727–736.
18.
Iwanaga, Yoshitaka, Masahiko Hoshijima, Yusu Gu, et al.. (2004). Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. Journal of Clinical Investigation. 113(5). 727–736.
19.
Hoshijima, Masahiko, Yasuhiro Ikeda, Yoshitaka Iwanaga, et al.. (2002). Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nature Medicine. 8(8). 864–871.
20.
Ryoke, Tsutomu, Yusu Gu, Yasuhiro Ikeda, et al.. (2002). Apoptosis and oncosis in the early progression of left ventricular dysfunction in the cardiomyopathic hamster. Basic Research in Cardiology. 97(1). 65–75.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Nancy D. Dalton Breakdown of academic impact, for papers by Seiji Takashima Breakdown of academic impact, for papers by Geir Christensen Breakdown of academic impact, for papers by Mark A. Sussman Breakdown of academic impact, for papers by Hanna Osińska Breakdown of academic impact, for papers by Michelle A. Sargent Breakdown of academic impact, for papers by Jutta Schaper Breakdown of academic impact, for papers by Michael Gotthardt Breakdown of academic impact, for papers by Christopher L. Antos Breakdown of academic impact, for papers by Jane‐Lise Samuel